Transcatheter aortic valve implantation (TAVI), also referred as
transcatheter aortic valve replacement, or percutaneous valve
replacement is a minimally invasive procedure that repairs the
functionality of the old and damaged valve. The aortic valve allows
the blood flow from the ventricle to the rest of the body. A
malfunction in the opening and closing of this valve leads to aortic
stenosis. The patients suffering from aortic stenosis suffer from
extra strain on the heart, which causes swelling in the ankles,
breathlessness, dizziness, chest pain, and frequent black outs. The
transcatheter aortic valve implantation is a procedure that allows
replacement of the aortic valve by implantation of a catheter.
Catheter is a long narrow tube that is inserted in the blood vessel
by making a small incision in the chest. The transcatheter aortic
valves are made from natural tissues of either a pig or a cow. This
natural tissue isolated from the heart of a pig or cow is then
re-engineered and reprocessed by attaching the valve to a flexible
and expandable mesh frame. Once the new valve is implanted, the
catheter is removed and the valve starts functioning normally.
Get
Sample Copy of This Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/918
High prevalence of aortic stenosis is responsible for growth of
the global transcatheter aortic valve implantation market
According to the Virtual Medical Centre (VMC) 2017, one in every four
people suffer from congenital valvular disease that may lead to the
development of Aortic stenosis at a young age. Additionally, people
aged 65 years and above are more likely to have degenerative aortic
stenosis due to calcification of the aortic valve or atherosclerosis.
Moreover, the American Heart Association statistics of 2017, states
that around 2200 deaths are experienced in the U.S. due to
cardiovascular diseases each day, accounting for 1 death every 40
seconds. .The same report also suggests that the coronary heart
disease is the leading cause of death in the U.S. accounting for
45.1% of deaths in the country. The rise in prevalence of
cardiovascular diseases and aortic stenosis provides immense
opportunities for key players to expand products and increase sales
over the forecast period.
The clinical trial success of the FDA approved devices drives
growth of the global transcatheter aortic implantation market
Several
novel TAVI devices that are in the last phases of the clinical
trials. For instance, in 2016, the SAPIEN XT by the Edward
Lifesciences has been FDA-approved and is now in the clinical phase
trial serving patients with intermediate risk. This serves as one of
the prime reasons for growth of the global
transcatheter aortic valve implants market.
Moreover, the success rate of the TAVI surgeries coupled with shorter
recovery time also help drive the global transcatheter aortic
implantation market growth. Apart from this, the high prevalence
rates of aortic stenosis and coronary artery diseases in the
geriatric population and younger population contributes to growth of
the global transcatheter aortic implantation market.
The key players operating in the global transcatheter aortic valve
implantation market include Direct Flow Medical Inc., Edwards
Lifesciences, Boston Scientific Corporartion, Jenavalve Technology,
Inc., HLT, Inc., Meril Life Sciences Pvt. Ltd., Medtronic Plc., St.
Jude Medical, Inc., Transcatheter Technologies GmbH, and SYMETIS SA.
On the basis of procedure, the global transcatheter aortic valve
implantation market is segmented into:
-
Transfemoral Implantation
-
Transapical Implantation
-
Transaortic Implantation
On the basis of end user, the global transcatheter aortic valve
implantation market is segmented into:
-
Hospitals
-
Diagnostic Labs
-
Ambulatory Surgical Centers
-
Clinics
-
Others
Request
For Customization of This Business Report @
https://www.coherentmarketinsights.com/insight/request-customization/918
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment